A drug discovery startup that uses proprietary technology to analyze molecular motion, uncovering previously untargeted disease-causing factors and developing therapeutic drugs. We conduct integrated research from basic studies to clinical development, aiming to create novel treatments.
[画像1: https://prtimes.jp/i/112397/6/resize/d112397-6-c5097506b43e9247a435-0.jpg ] ■企業概要 モルミルは、細胞内の分子の状態が変化することが疾病の兆候であることに注目し、その原因となる分子の動きを...
[画像: https://prtimes.jp/i/112397/5/resize/d112397-5-992c8af6c4f75cca2814-0.jpg ] モルミル（所在地：奈良県橿原市、代表取締役：森 英一朗）は、ALSを含む神経難病の治療薬開発に取り組んでおります。202...
[画像1: https://prtimes.jp/i/112397/4/resize/d112397-4-3f3b57f01653cc5b497b-0.png ] モルミル（所在地：奈良県橿原市、代表取締役：森 英一朗）は、これまでに奈良県立医科大学・産業技術総合研究所・徳島...
[画像1: https://prtimes.jp/i/112397/3/resize/d112397-3-a58a01245dcc35a22286-0.jpg ] モルミル（所在地：奈良県橿原市、代表取締役：森 英一朗）は、2022年6月の設立から1周年を迎えました。これまでに奈良...
[画像: https://prtimes.jp/i/112397/2/resize/d112397-2-518ceaf5c56d7a130b4e-1.png ]   岸田内閣も掲げる「科学技術立国の実現」に必要不可欠な1000名以上の有期雇用の研究人材が、今年3月末時点...
[画像1: https://prtimes.jp/i/112397/1/resize/d112397-1-5c2823994592d0265a04-4.jpg ] 現代生命科学の大きな命題「分子の動きを見る」ことが可能になれば、様々な生命現象・病態の解明に繋がることが期待...
A startup developing and selling products based on inclusive design, enabling both children with disabilities and non-disabled children to use them together. Leveraging family networks and practical expertise, it promotes a more inclusive society through corporate training, research, and co-development.
A femtech startup that develops period management apps and corporate health management support services, leveraging women's health data to simultaneously advance physical and mental care while addressing societal challenges.
Our mission is to safeguard the health of people worldwide. We are an Osaka University-spun-off healthcare startup in the healthcare/preventive medicine field, developing and providing the “Blood Vessel Beauty” scope—which observes capillary blood flow from the fingertip without blood sampling—along with the capillary image analysis software ‘CAS’ and the cloud-based evaluation system “CAS-Rating.” We research the relationship between capillary data and health/disease risks, aiming to implement new health indicators and preventive medical services in society.
A startup from Tokushima University providing genome-editing-based precision breeding services for agriculture and livestock, as well as contract testing for researchers. It accelerates industrial breeding and contributes to solving challenges through the power of biology.